TNF and COVID-19: A decreased risk of hospitalization or death was also associated with TNF inhibitor biologics compared with no treatment among 525 patients with inflammatory bowel disease and COVID‐19 reported to SECURE‐IBD (Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease).16